73360-54-0 Usage
Uses
Used in Medical Industry:
Bupivacaine Hydrochloride is used as a local anesthetic for providing pain relief during surgical procedures and other medical interventions. It acts by blocking the Na+ channels, preventing the transmission of nerve impulses and thus inducing local anesthesia.
Used in Pharmaceutical Industry:
Bupivacaine Hydrochloride is used as a cAMP production inhibitor, which can help regulate cellular processes and signaling pathways. This property makes it useful in the development of drugs targeting specific cellular mechanisms.
Used in Cosmetic Industry:
As a surfactant molecule with both hydrophilic and lipophilic properties, Bupivacaine Hydrochloride can be used in the formulation of cosmetic products to improve their stability, texture, and performance.
Used in Research Applications:
Bupivacaine Hydrochloride is used as an adrenergic antagonist, cholinesterase inhibitor, and Ca(2+)-transporting ATPase inhibitor in various research applications. These properties make it a valuable tool for studying the mechanisms of action of different biological processes and the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 73360-54-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,3,6 and 0 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 73360-54:
(7*7)+(6*3)+(5*3)+(4*6)+(3*0)+(2*5)+(1*4)=120
120 % 10 = 0
So 73360-54-0 is a valid CAS Registry Number.
73360-54-0Relevant academic research and scientific papers
Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
-
, (2015/09/28)
Disclosed are hydrogel compositions formed by the mixture of a tetramethylmethane substituted with one or more polyethylene glycols, and wherein each polyethylene glycol substituent is independently further substituted with one or more electrophilic groups, and a tetramethylmethane substituted with one or more polyethylene glycols, and wherein each polyethylene glycol substituent is independently further substituted with one or more nucleophilic groups. Disclosed are also methods of preparing the above hydrogels. The hydrogel compositions can further comprise pharmaceuticals, such as analgesics or local anesthetics. Disclosed are also methods of sealing a wound, preventing post-surgical adhesion, and reducing post-surgical pain using the disclosed hydrogels.
Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
-
, (2008/06/13)
An optically-enriched piperidine-2-carboxanlidecompound, in which the piperidine is optionally N-alkylated, is racemised by heating the compound in an aqueous medium, provided that the medium includes an organic co-solvent if the compound is N-alkylated. This process is particularly valuable, in conjunction with a resolution process, for the manufacture of levobupivacaine.
